Clinical Innovations hires Richard Ji as vice president of operations
Ji, who has more than two decades of operations leadership experience in the medical device industry, will be responsible for strengthening and streamlining operations throughout the Clinical Innovations organization. He was most recently the vice president of catheter solutions for global medical technology company Becton Dickinson.
“Richard’s industry experience and track record of leading teams to tremendous results make him ideally suited to leading Clinical Innovations’ operations as we continue to build and grow,” said Ken Reali, CEO and president. “We’re thrilled to have him on-board and look forward to the positive impact he’ll bring to all aspects of our business.”
An alumnus of Brigham Young University with an MBA from Duke University’s Fuqua School of Business, Ji joined Becton Dickinson in 1995 and quickly advanced through the company’s ranks in roles overseeing manufacturing, research, quality and supply chain. Noted for driving growth and efficiency, Ji held positions throughout the U.S. and overseas and, in his most recent role, oversaw an $800 million business with more than 1,200 employees.
“Clinical Innovations is a strong organization with a smart growth strategy and the results to show for it,” said Ji. “I’m honored to join such a talented team and look forward to accelerating those gains.”
Clinical Innovations develops and manufactures medical devices used before, during and after delivery to ensure optimal health outcomes for mothers and babies. The company, whose market-leading products are used in more than 90 countries, has been expanding domestically and internationally, acquiring Australian distributor JB Medical Supplies in June and German company Brenner Medical GmbH in summer 2017.
The Salt Lake City company, which is celebrating its quarter-century anniversary throughout 2018, is owned by EQT, a leading investment firm with approximately EUR 50 billion in raised capital across 27 funds.
About Clinical Innovations
Clinical Innovations is one of the largest medical device companies exclusively focused on labor and delivery and neonatal intensive care. The company is a market-leader in several categories with products such as the Koala® Intrauterine Pressure Catheter, Kiwi® Vacuum-Assisted Delivery System, ROM Plus® Rupture of Membranes Test, traxi® Panniculus Retractor, ClearView® Uterine Manipulator, the babyLance™ Safety heel stick and the ebb® Complete Tamponade System. Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is an EQT portfolio company. For more information, visit clinicalinnovations.com.
EQT is a leading investment firm with approximately EUR 50 billion in raised capital across 27 funds. EQT funds have portfolio companies in Europe, Asia and the U.S. with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT is an active investor and owner in the health care sector, including investments in Certara, Press Ganey, Ottobock, Sivantos, and Lima. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. For more information, visit EQTpartners.com.
Source: Clinical Innovations